BDX Q1 FY2026 earnings call recap: strong results, Waters Life Sciences deal, $4B buybacks/debt paydown, and outlook amid tariffs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results